Congressmembers Langworthy, Schrier Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
extensive research and development costs that are associated with these cutting-edge treatments, they are among the most … Campaign for Sustainable Rx Pricing (CSRxP), the Association for Accessible Medicines (AAM), the ERISA Industry Committee (ERIC